Skip to content

Clinical trials

Biliary Tract Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Not applicable Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20101
20112
20127
20133
20144
20151
20163
20181
20191
20205
20212
20223
20234
20244
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status11
Recruiting9
Not yet recruiting5
Terminated3
Active, not recruiting2
Suspended2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Universitari de Bellvitge5
National Cancer Center, Korea3
McGill University Health Centre/Research Institute of the McGill University Health Centre2
Peking University2
Affiliated Hospital to Academy of Military Medical Sciences1
Aichi Medical University1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1
Asan Medical Center1
Azienda USL 1 Imperiese1
Brno University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms53
Pancreatic Neoplasms22
Cholangiocarcinoma6
Colorectal Neoplasms6
Liver Neoplasms6
Gastrointestinal Neoplasms4
Stomach Neoplasms4
Appendiceal Neoplasms3
Colonic Neoplasms3
Duodenal Neoplasms3

Trials

Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.